AVENUE THERAPEUTICS, INC. (ATXI) Operating cash flow 2016–2025
AVENUE THERAPEUTICS, INC. (ATXI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.8MFY2025 · since FY2016: -$1.6M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | +79.7% |
| FY2024 | -$9.0M | +4.5% |
| FY2023 | -$9.5M | -24.4% |
| FY2022 | -$7.6M | -102.6% |
| FY2021 | -$3.8M | +18.7% |
| FY2020 | -$4.6M | +82.4% |
| FY2019 | -$26.3M | -44.2% |
| FY2018 | -$18.2M | -167.8% |
| FY2017 | -$6.8M | -316.8% |
| FY2016 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATXI financial trends
ATXI RevenueATXI Net incomeATXI Net marginATXI Gross profitATXI Gross marginATXI Operating incomeATXI Operating marginATXI Free cash flowATXI Capital expendituresATXI Return on equityATXI Stock buybacksATXI Dividends paidATXI Total assetsATXI Total liabilitiesATXI Shareholders’ equityATXI overview →